RAC, CTE, ADO: ASX health stocks with massive returns in past 3 years

May 28, 2022 12:45 AM AEST | By Aditi Sarkar
Follow us on Google News:


  • Multibagger stocks provide multiple times price return compared to their initial investment value
  • These stocks have strong fundamentals; however, they are undervalued
  • Business with a large scope of growth in a short period are potential multibaggers

Multibaggers are lucrative stocks that provide returns several times higher than their initial investment value. To be more specific, if a stock price rises by double, it's called a double bagger, while if the price grows multiple times, it's called a multibagger.

These stocks are usually undervalued and have strong fundamentals. Generally, businesses with huge room for growth in a short period can be considered as multibagger stocks.

This article will discuss three healthcare stocks from ASX that have provided a price return of multiple times their initial invested value.

Race Oncology Limited (ASX:RAC)

Race Oncology is a precision oncology company, currently involved in exploring the use of a cancer drug called Zantrene® as a new therapy for melanoma and clear cell renal cell carcinoma.

Image source: © 2022 Kalkine Media®

RAC has a market capitalisation of AU$298.51 million, and its share price has surged by nearly 2611% in the last three years.

Do read: ALT and CDX: Why these ASX healthcare stocks were in news today

Cryosite Limited (ASX: CTE)

Clinical trial in laboratory

Image source: © MinervaStudio   | Megapixl.com

Cryosite Limited is a fast-growing company which offers outsourced clinical trial logistic services.  It has 20 years of experience in managing clinical trial supply chains, including importation and storage of products.

In the half-year ended 31 December 2021, the company's profit after tax increased by a massive 175%. Similarly, cash on hand increased by AU$1.393M to AU$5.274M These results reaffirm the company’s growth profile established over the past three years.

Shares of CTE have provided a lucrative price return of about 1961% in the past three years and the company has a market cap of AU$33.19 million.

Also read: WFL, OSL, AVE: Three ASX healthcare stocks with over 20% QTD returns

AnteoTech Ltd (ASX: ADO)

AnteoTech, a surface chemistry company, has a market capitalisation of AU$208.83 million. The company's core technology product groups comprise AnteoCoat™, AnteoBind™ and AnteoRelease™.

Recently, ADO registered an updated EuGeni COVID-19 Rapid Antigen Test (RAT) in Europe under the In Vitro Diagnostic Directive (IVDD) 98/79/EC Regulations. This will offer an additional advantage to ADO as it develops the EuGeni COVID-19 RAT footprint in Europe.

Shares of Anteotech have prospered by nearly 629.5% in the last three years.

Embed video



The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK